GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMUC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for ImmunoCellular Therapeutics Ltd stock price on Friday
(Updated on Apr 19, 2024)

Sell candidate since Apr 17, 2024 Gain 31.93% PDF

The ImmunoCellular Therapeutics Ltd stock price gained 12.16% on the last trading day (Friday, 19th Apr 2024), rising from $0.176 to $0.198. During the last trading day the stock fluctuated 0% from a day low at $0.198 to a day high of $0.198. The price has risen in 5 of the last 10 days but is still down by -0.05% for this period. Volume fell on the last day by -188 shares and in total, 109 shares were bought and sold for approximately $21.57 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.206 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -52.22% during the next 3 months and, with a 90% probability hold a price between $0.0248 and $0.0983 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMUC Signals & Forecast

There are mixed signals in the stock today. The ImmunoCellular Therapeutics Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.209. On a fall, the stock will find some support from the short-term average at $0.163. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ImmunoCellular Therapeutics Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.183 and $0.152. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ImmunoCellular Therapeutics Ltd finds support just below today's level at $0.183. If this is broken, then the next support from accumulated volume will be at $0.152 and $0.152.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 8.82%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMUC) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect ImmunoCellular Therapeutics Ltd to open at $0.198, and during the day (based on 14 day Average True Range), to move between $0.147 and $0.249, which gives a possible trading interval of +/-$0.0513 (+/-25.92%) up or down from last closing price. If ImmunoCellular Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 51.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.183 (7.53%) than the resistance at $0.219 (10.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ImmunoCellular Therapeutics Ltd stock A Buy?

ImmunoCellular Therapeutics Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.432 Sell Candidate Unchanged

Predicted Opening Price for ImmunoCellular Therapeutics Ltd of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.198 ( 0%) $0.198

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMUC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.198 .
R2 0.198 .
R1 0.198 .
Current price: 0.198
Support S1 0.198 .
S2 0.198 .
S3 0.198 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.240 21.27 %
R2 0.230 16.22 %
R1 0.219 10.61 %
Current price 0.198
Support S1 0.183 -7.53%
S2 0.152 -23.19%
S3 0.152 -23.31%

FAQ

What is the symbol for ImmunoCellular Therapeutics Ltd Stock and on which exchange is it traded?
The symbol for ImmunoCellular Therapeutics Ltd is IMUC and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell ImmunoCellular Therapeutics Ltd Stock?
ImmunoCellular Therapeutics Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy ImmunoCellular Therapeutics Ltd Stock?
ImmunoCellular Therapeutics Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ImmunoCellular Therapeutics Ltd Stock.

What's the current price of ImmunoCellular Therapeutics Ltd Stock?
As of the end of day on the 2024-04-19, the price of an ImmunoCellular Therapeutics Ltd (IMUC) share was $0.198.

What is the 52-week high and low for ImmunoCellular Therapeutics Ltd Stock?
The 52-week high for ImmunoCellular Therapeutics Ltd Stock is $0.400 and the 52-week low is $0.110.

What is the market capitalization of ImmunoCellular Therapeutics Ltd Stock?
As of the 2024-04-19, the market capitalization of ImmunoCellular Therapeutics Ltd is 22.416M.
Click to get the best stock tips daily for free!

About ImmunoCellular Therapeutics Ltd

ImmunoCellular Therapeutics  Ltd Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also dev... IMUC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT